R & D Program Clause Samples

The R & D Program clause defines the framework and expectations for research and development activities conducted under an agreement. It typically outlines the scope of the R&D work, the responsibilities of each party, timelines, deliverables, and reporting requirements. For example, it may specify which technologies or products are being developed, how progress will be measured, and how results will be shared or owned. The core function of this clause is to ensure both parties have a clear understanding of their roles and obligations in the R&D process, thereby minimizing misunderstandings and facilitating successful collaboration.
R & D Program. The Proponent shall undertake a comprehensive research and development program intended to establish the commercial, technical and economic feasibility of hydrometallurgical process technology to process the Nickel Concentrate (the “R & D Program”). The R & D Program will include the evaluation of chemical engineering sub-processes for the hydrometallurgical process, the mechanical equipment design for the Demonstration Plant and the construction and operation of the Demonstration Plant.
View Source
R & D Program. Abbott has previously extended the R & D Program set forth in Article 2 beyond the initial Research Term, which ended June 15, 1997. The parties hereby agree to amend the R & D Program, with certain modifications, as follows: (i) The research and development services provided by ArQule to Abbott pursuant to Section 2.1. of the License Agreement shall continue until December 15, 1998, unless extended pursuant to paragraph (iii) below. [*]=CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. OMITTED TEXT IS INDICATED BY A “*”. (ii) Abbott shall by December 31, 1997 pay ArQule additional research and development funding of * Dollars ($*), which funding will support the research and development services provided by ArQule to Abbott pursuant to Section 2.1. of the License Agreement through December 15, 1998. (iii) Abbott may, at its option, extend the R & D Program for the one-year period commencing on December 16, 1998 and concluding on December 15, 1999, upon written notice to ArQule which is received by ArQule not later than June 15, 1998. The research and development funding for such one-year period shall be * Dollars ($*), payable in two equal installments of * Dollars ($*) with the first installment due on or before December 15, 1998 and the second installment due on or before June 15, 1999. (iv) The parties acknowledge and agree that the research and development funding set forth in this Article is calculated based on a rate of *Dollars ($*) per ArQule FTE per calendar year (the “FTE Rate”). ArQule shall have no obligation to perform services in the R & D Program without payment by Abbott at the FTE Rate. (v) This Article shall supersede Sections 2.3., 2.4.(c), and 2.4.(d) of the License Agreement.
View Source
R & D Program. 4.2.1 The Proponent shall undertake the R & D Program and as a part thereof shall construct the Demonstration Plant at a cost which the Proponent estimates will be $130 million. The Proponent shall commence the site development for the Demonstration Plant in 2002 and continue such development into 2003. The initiatives in support of these activities will include the operation of an information centre, preparation of environmental baseline studies and continued upgrading or replacement of utility services required for the Demonstration Plant, maintaining staging areas and cleanup and civil works at Argentia consisting of demolition, grading and earth works construction. The Proponent has scheduled the completion of the engineering, design and construction of the Demonstration Plant so that the Demonstration Plant Completion Date shall have occurred on or before 31 December 2006. 4.2.2 The Proponent shall provide to the Government within 15 days of the end of each calendar quarter commencing with the calendar quarter ending 31 December 2002, a detailed progress report on the results during such calendar quarter of the R & D Program, which report will detail costs incurred to the end of such calendar quarter and contain sufficient documentation and information to enable the Government to evaluate the Proponent’s progress with respect to the R & D Program and the development of hydrometallurgical process technology for processing the Nickel Concentrate. If requested by the Government, upon reasonable notice, the Proponent shall provide the Government and its representatives and advisors access, at reasonable times, to the facilities where the R & D Program is being conducted and make appropriate personnel of the Proponent available to respond to any requests for additional information. 4.2.3 In addition to the utilization of the Demonstration Plant for the purposes of developing hydrometallurgical process technology for processing the Nickel Concentrate, the Proponent shall explore business opportunities for the ongoing utilization of the Demonstration Plant for the evaluation of other concentrates and intermediate feeds after completion of the R & D Program.
View Source
R & D Program 
View Source

Related to R & D Program

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones) B. Estimated total development time

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Commercialization Plan On a Product by Product basis, not later than sixty (60) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory, the MSC shall prepare and approve a rolling multiyear (not less than three (3) years) plan for Commercializing such Product in the Copromotion Territory (the "Copromotion Territory Commercialization Plan"), which plan includes a comprehensive market development, marketing, sales, supply and distribution strategy for such Product in the Copromotion Territory. The Copromotion Territory Commercialization Plan shall be updated by the MSC at least once each calendar year such that it addresses no less than the three (3) upcoming years. Not later than thirty (30) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory and thereafter on or before September 30 of each calendar year, the MSC shall prepare an annual commercialization plan and budget (the "Annual Commercialization Plan and Budget"), which plan is based on the then current Copromotion Territory Commercialization Plan and includes a comprehensive market development, marketing, sales, supply and distribution strategy, including an overall budget for anticipated marketing, promotion and sales efforts in the upcoming calendar year (the first such Annual Development Plan and Budget shall cover the remainder of the calendar year in which such Product is anticipated to be approved plus the first full calendar year thereafter). The Annual Commercialization Plan and Budget will specify which Target Markets and distribution channels each Party shall devote its respective Promotion efforts towards, the personnel and other resources to be devoted by each Party to such efforts, the number and positioning of Details to be performed by each Party, as well as market and sales forecasts and related operating expenses, for the Product in each country of the Copromotion Territory, and budgets for projected Pre-Marketing Expenses, Sales and Marketing Expenses and Post-Approval Research and Regulatory Expenses. In preparing and updating the Copromotion Territory Commercialization Plan and each Annual Commercialization Plan and Budget, the MSC will take into consideration factors such as market conditions, regulatory issues and competition.

  • Development Plans Customer has provided Provider with a report attached hereto as Exhibit D (the “Current Development Plan”) describing in detail, as of January 1, 2017, the planned development, drilling, production, processing, treating, marketing and other activities to take place with respect to Dedicated Production and Customer Injected NGLs for the applicable Development Period. The information contained in the Current Development Plan is, with respect to the first three Years covered by the Current Development Plan, on a Quarter-by-Quarter basis, and with respect to the remaining Years covered by the Current Development Plan, on a Year-by-Year basis. The Current Development Plan attached hereto has been approved by the Parties. (a) From time to time during each Year of the Term, the Parties shall meet to discuss the planned development, drilling, production, processing, treating, marketing and other activities that Customer expects to take place with respect to Dedicated Production and Customer Injected NGLs for the then-applicable Development Period. Customer and Provider shall each make their respective representatives available to participate in such meetings and discussions. No later than August 1 of each such Year, Customer shall provide (or cause to be provided) to Provider a proposed update of the then-currently agreed Development Plan, prepared on the same basis as the Current Development Plan and describing in detail the planned development, drilling, production, processing, treating, marketing and other activities to take place with respect to Dedicated Production and Customer Injected NGLs for the then-applicable Development Period (any such update, an “Updated Development Plan” and, together with the Current Development Plan, each, a “Development Plan”). (b) Each proposed Development Plan shall include information as to the following, in each case, broken out, with respect to the first three Years covered by such Development Plan, on a Quarter-by-Quarter basis, and, with respect to the remaining Years covered by such Development Plan, on a Year-by-Year basis: (i) forward-looking production estimates for the applicable time period covered by such Development Plan for all Customer Gas and Customer Injected NGLs (A) that Customer reasonably and in good faith believes will become owned or Controlled by Customer during the time period covered by such Development Plan, and/or (B) that will be produced from (I) in the aggregate, all ▇▇▇▇▇ then-existing and (II) in the aggregate, all ▇▇▇▇▇ that are expected to be drilled during the time period covered by such Development Plan (each such Well reflected in such Development Plan, a “Planned Well” and, such collective estimates described in subsections (A) and (B), both with respect to a particular Quarter and an entire Year, the “Dedicated Production Estimates”); TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE CONFIDENTIAL TREATMENT FOR THOSE TERMS HAS BEEN REQUESTED. THE REDACTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION, AND THE TERMS HAVE BEEN MARKED AT THE APPROPRIATE PLACE WITH TWO ASTERISKS (**). (ii) (A) each new receipt point (including the location thereof) proposed by Customer with respect to the Dedicated Production Estimate reflected in such Development Plan (each such receipt point, a “Planned Receipt Point”), (B) each Receipt Point at which Customer expects to Tender Customer Gas or Customer Injected NGLs reflected in such Development Plan into the TGP System, and (C) the estimated portion of the Dedicated Production Estimate contained in such Development Plan that Customer expects to Tender at each such Receipt Point and Planned Receipt Point; (iii) (A) each new delivery point (including the location thereof) proposed by Customer with respect to the Dedication Production Estimate reflected in such Development Plan (each such delivery point, a “Planned Delivery Point”), (B) each Delivery Point at which Customer expects to Nominate Customer Residue Gas or Customer NGLs produced from the Dedicated Production Estimate reflected in such Development Plan to be redelivered to Customer, and (C) the estimated volumes of Customer Residue Gas and Customer NGLs produced from the Dedication Production Estimate contained in such Development Plan that Customer expects to Nominate to each such Delivery Point; (iv) the earliest date on which each Planned Receipt Point and Planned Delivery Point included in the Development Plan is required by Customer to be placed into service, which date shall not be earlier than three Months after the January 1st that is immediately subsequent to the date that the Development Plan that initially reflected such Planned Receipt Point or Planned Delivery Point was delivered to Provider hereunder; (v) the anticipated characteristics of the production from the ▇▇▇▇▇ and Planned ▇▇▇▇▇ reflected in such Development Plan (including liquids content and gas and liquids composition) and the projected production volumes and production pressures applicable thereto; provided that Customer may utilize the existing and historical production information from similarly situated ▇▇▇▇▇; (vi) any (A) proposed revision to the then-existing Dedicated Area and/or any then-existing Dedicated Contract and/or (B) any new contract that Customer proposes to be a Dedicated Contract; and (vii) other information reasonably requested by Provider that is relevant to the design, construction, and operation of the TGP System, including (A) any applicable Plant Expansion or Facilities Modification proposed by Customer, (B) the relevant Receipt Point and Planned Receipt Point facilities applicable to such Development Plan, and (C) the relevant Delivery Point and Planned Delivery Point facilities applicable to such Development Plan. TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE CONFIDENTIAL TREATMENT FOR THOSE TERMS HAS BEEN REQUESTED. THE REDACTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION, AND THE TERMS HAVE BEEN MARKED AT THE APPROPRIATE PLACE WITH TWO ASTERISKS (**).

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.